Comerica Bank’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18K | Buy |
1,284
+100
| +8% | +$1.4K | ﹤0.01% | 3077 |
|
|
2025
Q1 | $16.1K | Buy |
1,184
+89
| +8% | +$1.21K | ﹤0.01% | 3066 |
|
|
2024
Q4 | $22.3K | Buy |
1,095
+6
| +0.6% | +$122 | ﹤0.01% | 3001 |
|
|
2024
Q3 | $31.7K | Buy |
1,089
+674
| +162% | +$19.6K | ﹤0.01% | 2904 |
|
|
2024
Q2 | $9.64K | Buy |
415
+6
| +1% | +$139 | ﹤0.01% | 3160 |
|
|
2024
Q1 | $8.39K | Sell |
409
-202
| -33% | -$4.15K | ﹤0.01% | 3218 |
|
|
2023
Q4 | $13.1K | Buy |
611
+293
| +92% | +$6.29K | ﹤0.01% | 3090 |
|
|
2023
Q3 | $6.57K | Buy |
+318
| New | +$6.57K | ﹤0.01% | 3295 |
|